Analysis of the 677 C→T Mutation of the Methylenetetrahydrofolate Reductase Gene in Different Ethnic Groups

Summary

A recently described mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (a C to T transition at nucleotide 677) is associated with a thermolabile phenotype and decreased enzyme activity. In homozygotes, the mutation is also related to hyperhomocysteinemia and increased risk for atherosclerotic disease and (apparently) venous thrombosis. The prevalence of this mutation in different human populations is unknown. We have investigated the frequency of the 677 C→T mutation in the MTHFR gene in 337 individuals (674 chromosomes) belonging to four ethnic groups: Whites, African and Brazilian Blacks, Asians and Amerindians. The frequencies of the positive allele among Whites and Asians were similar to those previously reported for Caucasian populations. The positive allele seems to be slightly rarer among the Amerindians (frequency 24.0%) in comparison to Whites and Asians, with a heterogeneous distribution among the five Indian tribes analysed. In contrast, the mutation has a very low prevalence in Blacks, especially among the African Blacks, for whom the mutation was absent in homozygosity. Our data indicate that the 677 C→T MTHFR mutation has a significantly heterogeneous distribution among different ethnic groups, a fact that may contribute to explain geographical or racial differences in the risk for vascular disease.

• References

• 1 Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). “The metabolic and molecular bases of inherited disease”. 7th edition New York: McGraw-Hill; 1995: 3111-28.
• 2 Boers GHJ. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 1997; 78: 520-2.
• 3 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
• 4 Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-45.
• 5 Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylene-tetrahydrofolate reductase in coronary artery disease. Circulation 1993; 88: 1463-9.
• 6 Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylene tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
• 7 Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation ALA677→VAL in the methylene tetrahydrofolate reductase gene: a risk factor for premature arterial disease and venous thrombosis. Blood 1996; 88: 285a.
• 8 Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman CM, den Heyer M, Rozen R, Blom HJ. Mutated methylene-tetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1.
• 9 Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 1996; 58: 17-20.
• 10 Jacques PF, Boston AG, Williams RR, Elison RC, Eckfeldt JH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
• 11 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higushi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487.
• 12 Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 1997; 349: 473-4.
• 13 Zago MA, Santos EJM, Clegg JB, Guerreiro JF, Martinson JJ, Norwich J, Figueiredo MS. α-Globin gene haplotypes in South American Indians. Hum Biol 1995; 67: 535-46.
• 14 Zago MA, Silva Jr WA, Tavella MH, Santos SEB, Guerreiro JF, Figueiredo MS. Interpopulational and intrapopulational genetic diversity of Amerindians as revealed by six VNTRs. Hum Hered 1996; 46: 274-89.
• 15 Franco RF, Guerreiro JF, Zago MA, Figueiredo MS. Factor VIII gene polymorphisms in Amerindians from the Brazilian Amazon region. Braz J Genet 1996; 19: 351-4.
• 16 Franco RF, Araújo AG, Zago MA, Guerreiro JF, Figueiredo MS. Factor IX haplotypes in Amerindians. Hum Biol 1997; 69: 1-9.
• 17 McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. Thromb Res 1996; 83: 195-8.
• 18 Bortolini MC, Weimer TA, Franco MHLP, Salzano FM, Layrisse Z, Schneider H, Schneider MPC, Harada ML. Genetic studies in three South American Black populations. Gene Geography 1992; 6: 1-16.
• 19 Hames CG, Greenlund KJ. Ethnicity and cardiovascular disease: the Evans County heart study. Am J Med Sci 1996; 311: 130-4.